Form 4: Lemaitre Vascular Director Acquires Shares and Stock Options

Director Lawrence J. Jasinski of Lemaitre Vascular, Inc. acquired 420 shares of common stock and 2,594 stock options on December 6, 2024.

Summary

• Lawrence J. Jasinski, a director at Lemaitre Vascular, Inc., reported a transaction on December 6, 2024.
• He acquired 420 shares of common stock at a price of $0, increasing his direct holdings to 5,531 shares.
• Additionally, he acquired 2,594 stock options with an exercise price of $101.12, also on December 6, 2024.
• These options vest over a three-year period, with one-third vesting on the first anniversary and the remainder in equal annual installments.
• The stock options expire on December 6, 2029.

Sentiment

Score: 6

Explanation: The document is a routine filing of insider transactions. It is neither particularly positive nor negative, but the acquisition of shares and options by a director is generally viewed as a neutral to slightly positive sign.

Positives

• The acquisition of shares and stock options by a director could be seen as a positive sign of confidence in the company's future.

Future Outlook

The stock options vest over a three-year period, which could incentivize the director to contribute to the company's long-term success.

Industry Context

This is a standard SEC Form 4 filing, which is common for company insiders who trade their company's stock. It provides transparency into insider transactions.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The vesting schedule of the stock options is typical for executive compensation packages, aligning management's interests with long-term shareholder value.
• Comparable companies in the medical device industry also have similar insider trading reporting requirements.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment, as it indicates a director's confidence in the company.

Key Dates

Keywords

Lemaitre Vascular, Director, Stock Options, Share Acquisition, Form 4, Insider Trading, Equity Securities